Cellosaurus cell line TC587 (CVCL

Cross-references
Cell line name	TC587
Accession	CVCL_ZV62
Resource Identification Initiative	To cite this cell line use: TC587 (RRID:CVCL_ZV62)
Comments	Population: Japanese. Doubling time: ~36 hours (PubMed=32014918). Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
Sequence variations	Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Tyr (c.2446G>T); ClinVar=VCV000013860; Zygosity=Unspecified (PubMed=32014918). Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Unspecified (PubMed=32014918). Mutation; HGNC; HGNC:18118; RSF1; Simple; p.Pro1133Leu (c.3398C>T); Zygosity=Unspecified (PubMed=32014918). Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala347Asp (c.1040C>A); ClinVar=VCV000043587; Zygosity=Unspecified (PubMed=32014918).
Disease	Ovarian yolk sac tumor (NCIt: C8107) Yolk sac tumor (ORDO: Orphanet_876)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	12Y
Category	Cancer cell line
Publications	PubMed=32014918; DOI=10.21873/anticanres.14007 Takeshi Iwasaki, Kenichi Kohashi, Masasuke Ohno, Tomoaki Taguchi, Yoshinao Oda; Establishment and characterization of a novel primitive yolk sac tumour cell line, TC587. Anticancer Res. 40:759-766(2020)
Cell line databases/resources	cancercelllines; CVCL_ZV62
Encyclopedic resources	Wikidata; Q98133175
Entry history
Entry creation	02-Jul-2020
Last entry update	19-Dec-2024
Version number	8